Read the page behind the claim.

Find links to the state boards that handle doctors’ licences through the Federation of State Medical Boards.

The state board’s record is where to check a physician’s licence and public disciplinary history.

Use it for the name you have been given.

FDA, the U.S. drug regulator, has a lookup page linking to state pharmacy licence records.

A licence record confirms a licence; it does not prove that each medicine was dispensed properly.

Use the actual pharmacy name, rather than a care service’s logo.

As of September 26, 2026, the label for semaglutide (Wegovy) sets out approved uses and medical cautions.

A label is the official product information. The linked text is written for health professionals, so take unfamiliar words to your prescriber.

Use it to ask about the particular product.

FDA’s policy update checked September 26, 2026 describes the ended semaglutide shortage and restrictions on copies.

Compounding means making medicine to order. Read this source when an offer relies on an old shortage story.

STEP 1 compared semaglutide with a dummy shot containing no active medicine in adults without diabetes. Both groups also had advice about daily habits.

The journal record describes the study. Read who took part before treating its result as a forecast for you.

The Medicare Bridge page checked September 26, 2026 explains the temporary program and its eligibility conditions.

Read it with your prescriber and drug plan to check whether you can use the program. The monthly price alone does not tell you that.